Is There An Opportunity In Boston Scientific (BSX) After Steep Recent Share Price Declines?

robot
Abstract generation in progress

Boston Scientific (BSX) has experienced significant share price declines recently, with returns falling by 9.5% over 7 days and 37.6% over the past year. Despite these declines, a Discounted Cash Flow analysis suggests the stock is undervalued by 28.6% compared to its estimated intrinsic value of $88.10 per share. Additionally, its P/E ratio of 32.27x is below Simply Wall St’s proprietary “Fair Ratio” of 38.51x, further indicating a potential discount.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin